[{"Assets_0_Q2_USD":151846000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19255000.0,"NetIncomeLoss_1_Q2_USD":-13282000.0,"NetIncomeLoss_2_Q2_USD":-27167000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":131352000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":128101000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":131352000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":128101000.0,"StockholdersEquity_0_Q2_USD":90444000.0,"EarningsPerShareBasic_1_Q2_USD":-0.1,"EarningsPerShareBasic_2_Q2_USD":-0.21,"EarningsPerShareDiluted_1_Q2_USD":-0.1,"EarningsPerShareDiluted_2_Q2_USD":-0.21,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":15420000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":28984000.0,"Ticker":"CERS","CIK":"1020214","name":"CERUS CORP","OfficialName":"Cerus Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"830388885.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]